Mersiha Smajlovic's Contact Details

Mersiha Smajlovic's Company Details

ERGOMED

N/A, N/A, GB • 1000 - 4999 Employees
Major Drugs

Founded in 1997, Ergomed is a global provider of high-quality services to the biopharmaceutical industry, spanning all phases of clinical trials, post-approval pharmacovigilance, and medical information. Ergomed's fast-growing services business includes an industry-leading suite of specialist pharmacovigilance (PV) solutions, integrated under the PrimeVigilance brand, and Ergomed Clinical Research, a complete, global Phase I-IV clinical development and trial management services with a strong heritage in the development of drugs in rare diseases and oncology.• 1,400+ highly qualified professionals• Global full-service CRO• 25+ years of experience• Therapeutic specialization in oncology• Strong expertise in rare disease trials• Robust clinical safety system• Choice of leading drug safety databasesOur key services include:• Clinical Research Services• Pharmacovigilance• Medical Information• Regulatory• Medical Writing• Site Management• Study Physician Support• Biostatistics• Patient Study Support